India has emerged as a significant player in the global healthcare landscape, significantly shaping the accessibility and affordability of essential medicines. As the world's leading supplier of generic drugs, India's pharmaceutical industry services hundreds of millions of global citizens in need. By quantity, India accounts for 20% of global generic...
India’s Serum Institute Invests in Oxford Biomedica Plc
Pune, Maharshtra-based Serum Institute of India (SII) invested over $68 million in UK-based Oxford Biomedica plc, a gene and cell therapy company specializing in the development of gene-based medicines. Serum Life Sciences Ltd, a unit of SII, will pick up a 3.9% stake in Oxford Biomedica as part of the...
Biological E Invest $234 Million to Expand Vaccine Production
Privately held Indian company, Biological E is investing $234 million in their three facilities in the Genome Valley of Hyderabad, India. The new infusion of funds will enhance the production capacity by five billion doses, increasing the cumulative capacity to about 14 billion doses per year. The company claims that...
Serum Institute of India to Stockpile Vaccines for the World
On the outskirts of Pune, in India's western state of Maharashtra, at the 100-acre campus of Serum Institute of India (SII), CEO Adar Poonawalla proposes to set up a plug-and-play vaccine-making facility in preparation for the next pandemic. Since the facility can handle all different technologies, Poonawalla has offered 300,000 sq...
Germany Approves Bharat Biotech’s COVAXIN for Travel
German Ambassador to India and Bhutan, Walter J Lindner, announced that the government of Germany recognized WHO-listed Bharat Biotech's Covid vaccine, COVAXIN, for travel to the country starting June 1. In November last year the World Health Organization issued an emergency use listing for Covaxin, adding to a growing portfolio...
Six Indian Pharma Cos to Make Sputnik V Vaccines
Russia is expecting India to initially be making 50 million doses of its Sputnik V COVID-19 vaccines each month this summer, Kirill Dmitriev, head of Russian Direct Investment Fund, told reporters this month. India, the world’s second most populous nation, and the largest maker of vaccines in the world, approved...